To determine the proportion of fevers caused by leptospirosis, we obtained serum specimens and epidemiologic and clinical data from patients in Galle, Sri Lanka, March-October 2007. Immunoglobulin M ELISA was performed on paired serum specimens to diagnose acute (seroconversion or 4-fold titer rise) or past (titer without rise) leptospirosis and seroprevalence (acute). We compared (individually) the diagnostic yield of acute-phase specimens and clinical impression with paired specimens for acute leptospirosis. Of 889 patients with paired specimens, 120 had acute leptosoirosis and 241 had past leptospirosis. The sensitivity and specifi city of acute-phase serum specimens were 17.5% (95% confi dence interval [CI] 11.2%-25.5%) and 69.2% (95% CI 65.5%-72.7%), respectively, and of clinical impression 22.9% (95% CI 15.4%-32.0%) and 91.7% (95% CI 89.2%-93.8%), respectively. For identifying acute leptospirosis, clinical impression is insensitive, and immunoglobulin M results are more insensitive and costly. Rapid, pathogen-based tests for early diagnosis are needed.
L eptospirosis is an endemic zoonosis in the tropics, where a favorable climate enables the pathogenic spirochete Leptospira interrogans to survive in the environment (1) . Furthermore, many tropical residents have repeated direct and indirect exposures to infected animals that excrete leptospires in their urine (2) .
Sri Lanka, with a rapidly growing population of ≈20 million, has a reported annual incidence of leptospirosis of 5.4 cases/100,000 persons, the sixth highest incidence worldwide (3) . Approximately 28% of Sri Lanka's workforce is employed in agriculture, and reported cases of leptospirosis fl uctuate with rainfall and farming cycles. Historically, ≈200 cases per million population per year have been reported from the southern and north-central regions, where the disease is hyperendemic (3). However, incidence rates are imprecise estimates because leptospirosis is easily confused with undifferentiated fever of other causes (1) , and few cases are laboratory confi rmed (4) . In the past 2 decades, clinical cases have been increasingly reported (5), including >7,000 cases in 2008 (6) .
To determine the prevalence of acute and past leptospirosis in southern Sri Lanka, assess tools for acute diagnosis, and identify associated features, we collected epidemiologic and clinical data and paired serum specimens from a prospective cohort of children and adults with undifferentiated fever. The institutional review boards of the University of Ruhuna, Johns Hopkins University, and Duke University Medical Center approved this study.
Materials and Methods

Study Participants
We recruited patients in the emergency department, acute care clinics, and adult and pediatric wards of the Karapitiya Teaching Hospital in Galle, the largest (1,300-bed) hospital in southern Sri Lanka, during March-October 2007. We enrolled consecutive febrile (38°C, tympanic) patients >2 years old without antecedent (≤7 days) trauma or hospitalization who sought treatment during clinic hours (8:00 AM-4:00 PM Monday-Friday, and 8:00 AM-2:00 PM Saturday). Study doctors verifi ed patient eligibility and willingness to return for follow-up and obtained written informed consent from patients (>18 years of age) or parents (of those <18 years of age) and assent from those 12-17 years of age.
Study personnel recorded structured epidemiologic and clinical data, including duration of illness and the clinical provider's presumptive diagnosis, on a standardized form. Study doctors then obtained blood for on-site clinician-requested testing and subsequent off-site research-related testing. Patients returned for clinical and serologic follow-up 2-4 weeks later or were visited at home if they were unable to return and could be located. Blood was centrifuged, and serum specimens were frozen on site at −80°C, shipped on dry ice, and thawed only when separated into aliquots and when tested.
Serologic Testing
We tested paired serum specimens for the presence of specifi c Leptospira immunoglobulin (Ig) M by ELISA (Institut Viron Serion GmgH, Warburg, Germany), according to the manufacturer's instructions. Briefl y, rheumatoid factor (RF)-absorbent was fi rst diluted 1:4 in buffer. Serum specimens from patients and controls were then diluted (1:100) in RF-absorbent buffer to accomplish removal of IgM RF, transferred to antigen-coated microtest wells, and incubated at 37°C for 60 min. After wells were washed with phosphate-buffered saline, antihuman IgM (conjugated to alkaline phosphatase and p-nitrophenylphosphate) was added. After incubation of the wells for 20 min, sodium hydroxide was added to each well to stop the reaction, and the absorbance at 405 nm was measured.
The ELISA provided qualitative results-positive, negative, and equivocal (borderline positive/negative). Using a standard curve and evaluation table provided with the kit, we obtained the optical density measurements, which were adjusted for plate-to-plate variation with a correction factor and gave quantitative results that correlated with titers (7).
Case Defi nitions
Acute leptospirosis was defi ned as defi nitive seroconversion (negative acute-phase serum specimen to positive convalescent-phase serum specimen) or the equivalent of a 4-fold rise in IgM titer. We excluded from analyses of acute leptospirosis specimens with equivocal IgM test results or those lacking a convalescent-phase sample.
Past leptospirosis was defi ned as stable or decreasing IgM titers. We excluded from analyses of past leptospirosis specimens with equivocal IgM test results or those lacking a convalescent-phase sample. IgM seroprevalence was defi ned as the prevalence of leptospirosis by Leptospira IgM in acute-phase serum specimens, independent of whether a convalescent-phase specimen was obtained or its result.
Statistical Analysis
Proportions were compared by the χ 2 test or Fisher exact test and continuous variables by Student t test or the rank sum test if distribution was not normal. Confi dence intervals (CIs) for risk ratios were calculated by exact methods. We assessed IgM in the acute-phase sample for seroprevalence and clinical impression was compared with results of paired-serum specimen testing for acute leptospirosis. We specifi cally correlated epidemiologic features, duration of illness, and symptoms and signs with serologic test results. Analyses were performed with Stata IC 11.0 (StataCorp LP, College Station, TX, USA).
Results
Patient Characteristics
Paired serum specimens were available from 889 (82.4%) of 1,079 patients consecutively enrolled. Among those, a diagnosis of acute leptospirosis could be confi rmed or refuted for 773 (87.0%) of 889, because serologic results were inconclusive for 116. The likelihood of a participant's returning for convalescent-phase serum sampling and clinical follow-up did not differ by age (p = 0.10). Female patients were slightly more likely to return for follow-up (85.8 vs. 80.6%; p = 0.03). Most (90.2%) patients lived in rural areas and were more likely to return for follow-up than were those who lived in urban areas (83.5 vs. 71.4%; p = 0.002). The proportion with secondary education was similar in the 2 groups (21.7 vs. 19.6%; p = 0.51), as was reported duration of fever and of illness (p = 0.15 and p = 0.13, respectively).
Of the 773 patients with conclusive serologic results, the median age was 30.1 years (interquartile range [IQR] 19-47 years). More patients were male (60.6%) than female, and the median age did not differ by sex (p = 0.78). The median reported duration of fever and of illness was 3 days (IQR 2-5 days and 2-7 days, respectively). Many (37.6%) reported taking an antimicrobial drug before seeking treatment. The median interval between acutephase and convalescent-phase follow-up was 21 days (IQR 15-33 days).
Diagnosis of Acute Leptospirosis
Acute leptospirosis was confi rmed for 120 patients ( Figure 1 ): by seroconversion for 96 patients and by a 4-fold rise in titer for 24 patients (in 21 acute-phase specimens with positive results and in 3 acute-phase specimens with equivocal results); acute leptospirosis was excluded for 653 patients. Data on presumptive clinical diagnosis were available for 714 patients, including for 109 of 120 with acute leptospirosis. Of these patients, 25 received a correct diagnosis of acute leptospirosis, and 84 received an incorrect diagnosis of another disease. The sensitivity and specifi city of clinical impression were 22.9% (95% CI 15.4%-32.0%) and 91.7% (95% CI 89.2%-93.8%), respectively. Finally, 279 patients were seropositive at enrollment, including 201 with past leptospirosis, 40 with possible recent leptospirosis (second specimen equivocal), 21 with acute leptospirosis, and 57 without paired serum specimens. Therefore, if acute-phase IgM had been used to diagnose acute leptospirosis instead of paired serum specimens, only 21 of 120 acute infections would have been identifi ed (sensitivity 17.5%, 95% CI 11.2%-25.5%), and 201 of 653 patients without acute leptospirosis would have been given an erroneous diagnosis (specifi city 69.2%, 95% CI 65.5%-72.7%). Thus, IgM seropositivity at the acute-phase visit correlated poorly with acute leptospirosis.
Demographic Features of Patients with Acute or Past Leptospirosis
The demographic characteristics of patients are listed in Table 1 . Those with acute or past leptospirosis were older (median 32 years vs. 27 years; p = 0.01) than those without acute or past leptospirosis. Reporting exposure to paddy fi elds (relative risk [RR] 1.9, 95% CI 1.6-2.1; p<0.0001) and working as a farmer (RR 1.9, 95% CI 1.6-2.3; p = 0.0001) were strongly associated with acute and past leptospirosis. Reporting no fresh water exposure and boiling drinking water were protective against leptospirosis. Patients enrolled during March-June were less likely to have acute leptospirosis than those enrolled during JulyOctober ( Figure 2 ). Children <10 years of age were much less likely to have acute or past leptospirosis; in contrast, leptospirosis was more common in older adolescents and young adults (Figure 3) .
The median duration of illness at hospital visit for those with acute leptospirosis diagnosed by seroconversion was 3 days (IQR 2-5 days), and for those with acute leptospirosis diagnosed by a 4-fold rise in titer, 4 days (IQR 3-5 days; p = 0.09). The median interval between serum sampling was 22 days (IQR 15-31 days). The follow-up time was slightly longer for those with leptospirosis diagnosed by 4-fold change in titer than for those with diagnosis by seroconversion (median 26 vs. 20 days; p = 0.08). The median age was 33.6 years (IQR 18.7-45.6 years), and more patients were male (69.2%) than female (p = 0.07).
Clinical Features of Acute Leptospirosis
Clinical features associated with acute leptospirosis are listed in Table 2 . Headache was the most frequent (≈80%) symptom reported; lethargy, muscle pain, and joint pain were also reported by >50% of patients. Lethargy and cough Among those who died, the acute-phase serum specimen was IgM-negative for 8 patients, IgM-positive for 2, and results were equivocal for 1.
Discussion
We found that leptospirosis was a common, but often clinically unsuspected, cause of fever among unselected patients seeking care in southern Sri Lanka. Farming and rice paddy work were associated with increased risk for leptospirosis, as was exhibiting acute febrile illness during the harvesting season (July-October). In our setting, testing acute-phase serum specimens alone for IgM was less sensitive and specifi c for diagnosing acute leptospirosis than was diagnosis by observation of clinical features.
Isolation of Leptospira spp. confi rms acute infection, but requires special media that must be incubated for up to 13 weeks, and has low sensitivity (1). Therefore, the diagnostic standard for acute leptospirosis is a defi nitive rise in titer between paired serum specimens (1). Historically, these results have been obtained by the microscopic agglutination test (MAT). Serum specimens are fi rst reacted with live antigen suspensions of different leptospiral serovars. After incubation, the serum-antigen mixtures are examined and titers determined. For paired serum specimens, the highest dilution of serum at which 50% agglutination occurs must be determined, a laborious and inherently subjective task (1).
Sensitivity is compromised if all locally relevant serovars are not represented, and live cultures of all serovars tested must be maintained whether live or formalin-killed antigens are used. Subculturing many Leptospira spp. weekly is hazardous for personnel, and laboratory-acquired infections occur (1) . Reading a MAT requires a dark-fi eld microscope, which is unavailable in most laboratories, including Karapitya Teaching Hospital. Furthermore, a MAT detects both IgM and IgG and lacks sensitivity and specifi city when early acute-phase serum specimens alone are tested rather than paired specimens (1). Patients with fulminant illness may die before seroconversion occurs. A MAT may also be less sensitive than an IgM ELISA, even for convalescent-phase specimens. Relative to isolation of Leptospira spp., the reported sensitivities of MATs for acute, late acute-phase, and convalescent-phase serum specimens were 30%, 63%, and 76%, respectively, and of IgM ELISA, 52%, 89%, and 93%, respectively, in 1 study in Barbados (8) . In another study, results of MAT and IgM ELISA for a single early acute-phase specimen were comparable (49%) (9) .
To overcome the practical pitfalls of MATs, we chose to test paired serum specimens by IgM ELISA, which requires only an inexpensive plate reader, is relatively easy to perform, and provides objective, reproducible results as demonstrated by a parallel comparison of results of multiple commercial assays (9) . Furthermore, results of performing IgM ELISA on paired serum specimens from patients from various geographic regions have compared favorably (sensitivity 86.5%, specifi city 97.0%) with MAT results (10) . These data suggest that at least 13.5% of febrile illnesses in our cohort were acute leptospirosis. We assayed paired specimens for IgM instead of IgG, because the kinetics of IgG are more variable (11, 12) . IgM generally appears within 1 week of symptoms and persists for months to years after infection (13) with titers higher than those of IgG throughout (11, 14) . Additionally, in some patients for whom leptospirosis is confi rmed by culture and MAT, IgG never develops (11, 13) .
We chose a commercially available IgM ELISA that has performed comparably to others in detecting serovars likely present in southern Sri Lanka (9) . IgM is inherently cross-reactive, and thus serovars themselves are not detected. In a recent study from central Sri Lanka, the predominant serovars were Mednensis and Hardjo, but others included Australis, Ballum, Canicola, Celledoni, Cynopteri, Pomona, and Robinsoni (15) . Previously, identifi cation of the serovar Icterhemorrhagiae in Sri Lanka led to control of the rodent vector (16) . The assay we used has reliably reacted with serovars Icterohemorrhagiae, Canicola, Grippotyphosa, Bataviae, Pomona, Tarassovi, Copenhageni, Bratislava, Hebdomadis, Sejroe, Australis, Panama, Pyrogenes, Patoc, Hardjo, and Cynopteri (7, 17) .
Notably, detection of acute-phase IgM did not predict which patients had acute leptospirosis, despite its widespread use as an acute diagnostic test. Retrospective studies suggest sensitivities and specifi cities of 36%-53% for single acute-phase IgM and 90%-99% for MAT on paired serum specimens, respectively (9,10). The varied sensitivity likely refl ects different case defi nitions and control groups, timing of acute-phase specimen collection (up to 42 days after onset), geography and serovar distribution, platforms and protocols (e.g., ELISA ± use of RF absorbent, indirect hemagglutination, and dot-ELISA and IgM dipsticks), and convenience sampling. Notably, ELISA of single (acutephase) serum specimens has performed as well or better than MAT or indirect hemagglutination of single serum specimens, so those strategies are not advised (10) .
The most widely recognized problem with using acute-phase IgM to identify acute leptospirosis is that Only a few studies have evaluated the use of serologic testing for identifying leptospirosis in febrile cohorts. In Laos, 372 febrile patients were evaluated with ELISA (Panbio Ltd., Brisbane, Queensland, Australia) and immunochromatographic testing (ICT), which was compared with the MAT; acute leptospirosis (single titer >400 or 4-fold rise in titer) was identifi ed in 23 (12.4%) of 186 patients (18) . The sensitivity of ELISA and ICT was relatively high (60.9% and 47.3%, respectively), which could be explained by a long duration of fever (median 9 days). The sensitivity of ELISA for acute-phase versus convalescent-phase serum specimens was comparable (60.9% and 65.2%, respectively), but convalescent-phase serum specimens were obtained 4.5 days after acute-phase serum specimens. The specifi city of both assays was similarly poor (65.6% for ELISA and 75.5% for ICT). In Thailand, Cohen et al. identifi ed acute leptospirosis in 67 (9.5%) of febrile subjects using 2 rapid assays, a dipstick, and latex slide agglutination test (19) . Patients sought treatment after a mean of 3.4 days of fever and returned 22 days later. Compared with MAT on paired serum specimens, the sensitivity of testing acute-phase serum with the dipstick and latex slide agglutination tests was 22% and 13%, respectively, which is similar to our fi ndings.
Strengths of our study include the rigorous, prospective design, uniquely large sample size, inclusion of an unstudied population believed to be at high risk, an unusually high rate of follow-up, and clinical correlation. To minimize selection bias, we used standardized criteria to sequentially enroll a large cohort (≈900 patients) with thorough followup to enable assessment of acute-phase IgM testing versus clinical impression and relevant epidemiologic and clinical features. Those patients from whom paired serum specimens were not available differed only slightly from the included population. We excluded the few with equivocal results to avoid possible misclassifi cation with resultant potential failure to identify signifi cant predictive clinical features. By rigorously distinguishing acute from recent leptospirosis, we were able to confi rm that myalgias and arthralgia were frequent symptoms and that the presence of conjunctivitis or conjunctival suffusion is diagnostically helpful. Leptospirosis in this cohort was relatively mild, as evidenced by stable vital signs, the absence of jaundice, and complete blood counts within nearly normal ranges. The sparse laboratory data refl ect standard clinical practice in which automated testing is largely unavailable in the public sector, expensive in the private sector, and thus infrequently obtained.
Our results might have differed if we had used a different diagnostic standard, but culture, for example, is insensitive, labor intensive, unlikely to be available soon at Karapitya Teaching Hospital and many similar hospitals, and too slow to guide clinical management. We may have misclassifi ed the number of days with fever, since temperatures are infrequently taken at home or in the hospital; however, duration of fever correlated well with that of symptoms, and no systematic bias would be expected, since etiologic diagnoses were not known when patients sought treatment at the hospital. Our estimate of leptospirosis may be low if a wider array of serovars is circulating in southern Sri Lanka than were detected by the ELISA used; however, no other available commercial assay would have been expected to be more sensitive.
We conclude that leptospirosis causes substantive illness in southern Sri Lanka. Furthermore, we found that testing acute-phase serum specimens for IgM has multiple limitations for the diagnosis of acute leptospirosis, because a positive result more often denoted past infection than an acute infection, and results were negative early in infection. Clinical impression is comparatively better without added cost (20) . Paired serum specimens can provide rigorous diagnosis, but patients and clinicians need rapid diagnosis to guide clinical management. A few antigen-based or nucleic acid-based rapid tests have been described, but prospective clinical validations are limited (17, (21) (22) (23) (24) (25) . Rapid, pathogen-based tests for early diagnosis need to be developed.
